Molecular Docking Studies of Interaction Curcumin against Beta-secretase 1, Amyloid A4 Protein, Gamma-secretase and Glycogen Synthase Kinase-3β as Target Therapy for Alzheimer Disease

Mokhamad Fahmi Rizki Syaban; Rislan Faiz Muhammad; Basyar Adnani; Gumilar Fardhani Ami Putra; Nabila Erina Erwan; Safira Dita Arviana; Agung Dwi Krisnayana; Dedy Budi Kurniawan

doi:10.52711/0974-360X.2022.00513

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Molecular Docking Studies of Interaction Curcumin against Beta-secretase 1, Amyloid A4 Protein, Gamma-secretase and Glycogen Synthase Kinase-3β as Target Therapy for Alzheimer Disease

Author(s): Mokhamad Fahmi Rizki Syaban, Rislan Faiz Muhammad, Basyar Adnani, Gumilar Fardhani Ami Putra, Nabila Erina Erwan, Safira Dita Arviana, Agung Dwi Krisnayana, Dedy Budi Kurniawan

Email(s): mokhamadfahmi@gmail.com

DOI: 10.52711/0974-360X.2022.00513

Address: Mokhamad Fahmi Rizki Syaban1*, Rislan Faiz Muhammad2, Basyar Adnani2, Gumilar Fardhani Ami Putra2, Nabila Erina Erwan2, Safira Dita Arviana2, Agung Dwi Krisnayana1, Dedy Budi Kurniawan2
1Faculty of Medicine, Brawijaya Univesity, Malang, 65111 Indonesia.
2Master Program in Biomedical Science, Faculty of Medicine, Brawijaya Univesity, Malang, 65111, Indonesia.
*Corresponding Author

Published In: Volume - 15, Issue - 7, Year - 2022

Keywords:

Cite this article:
Mokhamad Fahmi Rizki Syaban, Rislan Faiz Muhammad, Basyar Adnani, Gumilar Fardhani Ami Putra, Nabila Erina Erwan, Safira Dita Arviana, Agung Dwi Krisnayana, Dedy Budi Kurniawan. Molecular Docking Studies of Interaction Curcumin against Beta-secretase 1, Amyloid A4 Protein, Gamma-secretase and Glycogen Synthase Kinase-3β as Target Therapy for Alzheimer Disease. Research Journal of Pharmacy and Technology. 2022; 15(7):3069-4. doi: 10.52711/0974-360X.2022.00513

View PDF